vs

Side-by-side financial comparison of CollPlant Biotechnologies Ltd (CLGN) and MSA Safety Inc (MSA). Click either name above to swap in a different company.

MSA Safety Inc is the larger business by last-quarter revenue ($510.9M vs $179.0K, roughly 2854.3× CollPlant Biotechnologies Ltd). MSA Safety Inc runs the higher net margin — 17.0% vs -1869.8%, a 1886.8% gap on every dollar of revenue. On growth, MSA Safety Inc posted the faster year-over-year revenue change (2.2% vs -28.1%).

CollPlant Biotechnologies Ltd is a regenerative medicine company focused on developing and commercializing advanced products using its proprietary plant-derived human collagen technology. Its core offerings cover wound care, soft tissue repair, and aesthetic medicine solutions, targeting key markets across North America, Europe, and Israel, serving healthcare providers in dermatology, orthopedics and cosmetic care segments.

Mine Safety Appliances, or MSA Safety Incorporated, is an American manufacturer and supplier of safety equipment designed for use in a variety of hazardous conditions in industries such as construction, the military, fire service, and chemical, oil, and gas production. MSA is based in the Pittsburgh suburb of Cranberry.

CLGN vs MSA — Head-to-Head

Bigger by revenue
MSA
MSA
2854.3× larger
MSA
$510.9M
$179.0K
CLGN
Growing faster (revenue YoY)
MSA
MSA
+30.4% gap
MSA
2.2%
-28.1%
CLGN
Higher net margin
MSA
MSA
1886.8% more per $
MSA
17.0%
-1869.8%
CLGN

Income Statement — Q2 2025 vs Q4 2025

Metric
CLGN
CLGN
MSA
MSA
Revenue
$179.0K
$510.9M
Net Profit
$-3.3M
$86.9M
Gross Margin
-3.9%
46.9%
Operating Margin
-1775.4%
22.3%
Net Margin
-1869.8%
17.0%
Revenue YoY
-28.1%
2.2%
Net Profit YoY
20.5%
-1.2%
EPS (diluted)
$0.28
$2.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLGN
CLGN
MSA
MSA
Q4 25
$510.9M
Q3 25
$468.4M
Q2 25
$179.0K
$474.1M
Q1 25
$421.3M
Q4 24
$499.7M
Q3 24
$432.7M
Q2 24
$249.0K
$462.5M
Q1 24
$413.3M
Net Profit
CLGN
CLGN
MSA
MSA
Q4 25
$86.9M
Q3 25
$69.6M
Q2 25
$-3.3M
$62.8M
Q1 25
$59.6M
Q4 24
$87.9M
Q3 24
$66.6M
Q2 24
$-4.2M
$72.2M
Q1 24
$58.1M
Gross Margin
CLGN
CLGN
MSA
MSA
Q4 25
46.9%
Q3 25
46.5%
Q2 25
-3.9%
46.6%
Q1 25
45.9%
Q4 24
46.9%
Q3 24
47.9%
Q2 24
-115.3%
48.2%
Q1 24
47.3%
Operating Margin
CLGN
CLGN
MSA
MSA
Q4 25
22.3%
Q3 25
20.1%
Q2 25
-1775.4%
18.1%
Q1 25
18.5%
Q4 24
23.5%
Q3 24
21.1%
Q2 24
-1769.5%
21.6%
Q1 24
19.4%
Net Margin
CLGN
CLGN
MSA
MSA
Q4 25
17.0%
Q3 25
14.9%
Q2 25
-1869.8%
13.2%
Q1 25
14.1%
Q4 24
17.6%
Q3 24
15.4%
Q2 24
-1690.8%
15.6%
Q1 24
14.1%
EPS (diluted)
CLGN
CLGN
MSA
MSA
Q4 25
$2.22
Q3 25
$1.77
Q2 25
$0.28
$1.59
Q1 25
$1.51
Q4 24
$2.22
Q3 24
$1.69
Q2 24
$0.37
$1.83
Q1 24
$1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLGN
CLGN
MSA
MSA
Cash + ST InvestmentsLiquidity on hand
$11.4M
$165.1M
Total DebtLower is stronger
$580.9M
Stockholders' EquityBook value
$12.5M
$1.4B
Total Assets
$17.4M
$2.6B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLGN
CLGN
MSA
MSA
Q4 25
$165.1M
Q3 25
$170.0M
Q2 25
$11.4M
$147.0M
Q1 25
$170.6M
Q4 24
$164.6M
Q3 24
$154.4M
Q2 24
$18.9M
$146.8M
Q1 24
$148.3M
Total Debt
CLGN
CLGN
MSA
MSA
Q4 25
$580.9M
Q3 25
$628.6M
Q2 25
$679.3M
Q1 25
$502.1M
Q4 24
$508.0M
Q3 24
$554.7M
Q2 24
$588.2M
Q1 24
$596.2M
Stockholders' Equity
CLGN
CLGN
MSA
MSA
Q4 25
$1.4B
Q3 25
$1.3B
Q2 25
$12.5M
$1.3B
Q1 25
$1.2B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$20.7M
$1.0B
Q1 24
$994.8M
Total Assets
CLGN
CLGN
MSA
MSA
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$17.4M
$2.6B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$26.6M
$2.2B
Q1 24
$2.2B
Debt / Equity
CLGN
CLGN
MSA
MSA
Q4 25
0.42×
Q3 25
0.48×
Q2 25
0.54×
Q1 25
0.42×
Q4 24
0.44×
Q3 24
0.51×
Q2 24
0.57×
Q1 24
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLGN
CLGN
MSA
MSA
Operating Cash FlowLast quarter
$122.4M
Free Cash FlowOCF − Capex
$106.0M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$295.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLGN
CLGN
MSA
MSA
Q4 25
$122.4M
Q3 25
$112.5M
Q2 25
$67.2M
Q1 25
$61.8M
Q4 24
$107.9M
Q3 24
$84.3M
Q2 24
$53.3M
Q1 24
$50.9M
Free Cash Flow
CLGN
CLGN
MSA
MSA
Q4 25
$106.0M
Q3 25
$100.5M
Q2 25
$37.9M
Q1 25
$51.0M
Q4 24
$93.5M
Q3 24
$70.1M
Q2 24
$39.0M
Q1 24
$39.7M
FCF Margin
CLGN
CLGN
MSA
MSA
Q4 25
20.8%
Q3 25
21.4%
Q2 25
8.0%
Q1 25
12.1%
Q4 24
18.7%
Q3 24
16.2%
Q2 24
8.4%
Q1 24
9.6%
Capex Intensity
CLGN
CLGN
MSA
MSA
Q4 25
3.2%
Q3 25
2.6%
Q2 25
6.2%
Q1 25
2.6%
Q4 24
2.9%
Q3 24
3.3%
Q2 24
3.1%
Q1 24
2.7%
Cash Conversion
CLGN
CLGN
MSA
MSA
Q4 25
1.41×
Q3 25
1.62×
Q2 25
1.07×
Q1 25
1.04×
Q4 24
1.23×
Q3 24
1.27×
Q2 24
0.74×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLGN
CLGN

Segment breakdown not available.

MSA
MSA

Americas Segment$335.2M66%
International Segment$175.7M34%

Related Comparisons